Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Dr. Reddy's Laboratories Ltd

NSE: DRREDDY · BSE: 500124 · Pharmaceuticals & Biotechnology · 45 announcements

Dr. Reddy's Laboratories Ltd news stories on ALFA NewsRead the news →
Share price
₹1,203.80
Market cap
₹1,00,478 Cr
Revenue (annual)
₹33,700 Cr
Net profit (annual)
₹4,196 Cr
P/E (TTM)
31.2×Sector 47.4×
Promoter holding
26.64%+0.01% QoQ
FII holding
20.67%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:02 IST BSE
Board Meeting Outcome

Dr. Reddy's Laboratories Board Meeting Outcome

Dr. Reddy's Board approved the re-appointment of Dr. K P Krishnan and appointed Mr. Srikanth Velamakanni as Independent Directors. These appointments strengthen corporate governance and leadership.

16:21 IST NSE
Board Meeting Outcome

Dr. Reddy's Laboratories Board Meeting Outcome

Dr. Reddy's Laboratories Limited has scheduled a board meeting on May 12, 2026, to consider a final dividend. The trading window for designated persons is closed from March 25, 2026, until May 14, 2026.

15:41 IST BSE
Board Meeting Outcome

Dr. Reddy's Laboratories Board Meeting Outcome

Dr. Reddy's Laboratories Ltd has scheduled a Board of Directors meeting to consider recommending a final dividend for the financial year 2025-26. This follows a prior intimation dated March 23, 2026.